NEFL and myeloid sarcoma: Both values provided supplementary information of the MS phenotype with higher values of NFL that seemed to correspond more frequently to active patients (most in the RRMS subgroup) susceptible to respond to current DMT, while higher values of CHI3L1 were associated with progressive MS (more evident for PPMS).